Clinical Trial Update: Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial evaluating chemotherapy and/or hormone therapy with or without zoledronate in women with stage II or stage III breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: University of Sheffield | Conditions: Breast Cancer, Metastatic Cancer | Phase 3 | Status: UNKNOWN